The β2-adrenoceptor agonist terbutaline recovers rat pharyngeal dilator muscle force decline during severe hypoxia

Oral Diseases

Volumn 21, Issue 1, 2015, Pages e121-e127

  Mcdonald, F B ^a   Skelly, J R ^a   O'Halloran, K D ^a,b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Hypoxia; Obstructive sleep apnoea syndrome; Sternohyoid; 2 adrenoceptor agonist

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPRANOLOL; TERBUTALINE;

ANIMAL; DRUG EFFECTS; HYPOXIA; MALE; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; PHARYNGEAL MUSCLE; PHYSIOLOGY; RAT; WISTAR RAT;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; HYPOXIA; MALE; MUSCLE CONTRACTION; PHARYNGEAL MUSCLES; PROPRANOLOL; RATS; RATS, WISTAR; TERBUTALINE;

EID: 84919360554     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12247     Document Type: Article

References (80)

1. Aubier M, Viires N, Murciano D, Medrano G, Lecocguic Y, Pariente R (1984). Effects and mechanism of action of terbutaline on diaphragmatic contractility and fatigue. J Appl Physiol Respir Environ Exerc Physiol 56: 922-929.
2. Bachman ES, Dhillon H, Zhang C-Y et al (2002). Beta AR signaling required for diet-induced thermogenesis and obesity resistance. Science 297: 843-845.
3. Beermann DH, Butler WR, Hogue DE et al (1987). Cimaterol-induced muscle hypertrophy and altered endocrine status in lambs. J Anim Sci 65: 1514-1524.
4. Bowman WC, Nott MW (1969). Actions of sympathomimetic amines and their antagonists on skeletal muscle. Pharmacol Rev 21: 27-72.
5. Boyaci H, Gacar K, Bariş SA, Başyiğit I, Yildiz F (2013). Positive airway pressure device compliance of the patients with obstructive sleep apnea syndrome. Adv Clin Exp Med 22: 809-815.
6. Bradford A, McGuire M, O'Halloran KD (2005). Does episodic hypoxia affect upper airway dilator muscle function? Implications for the pathology of obstructive sleep apnea. Resp Physiol Neurobiol 147: 223-234.
7. Buchanan R, Nielsen OB, Clausen T (2002). Excitation- and beta(2)-agonist-induced activation of the Na(+)-K(+) pump in rat soleus muscle. J Physiol 545: 229-240.
8. Burniston JG, McLean L, Beynon RJ, Goldspink DF (2007). Anabolic effects of a non-myotoxic dose of the beta2-adrenergic receptor agonist clenbuterol on rat plantaris muscle. Muscle Nerve 35: 217-223.
9. Busquets S, Figueras MT, Fuster G et al (2004). Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting. Cancer Res 64: 6725-6731.
10. Cairns SP, Dulhunty AF (1993). The effects of beta-adrenoceptor activation on contraction in isolated fast- and slow-twitch skeletal muscle fibres of the rat. Br J Pharmacol 110: 1133-1141.
11. Carter WJ, Lynch ME (1994). Comparison of the effects of salbutamol and clenbuterol on skeletal muscle mass and carcass composition in senescent rats. Metab, Clin Exp 43: 1119-1125.
12. Charbonneau M, Marin JM, Olha A, Kimoff RJ, Levy RD, Cosio MG (1994). Changes in obstructive sleep apnea characteristics through the night. Chest 106: 1695-1701.
13. Clausen T (1983). Adrenergic control of Na+-K+-homoeostasis. Acta Med Scand Suppl 672: 111-115.
14. Collet F, Féve B, Frisdal E, Pavoine C, Pecker F, Atlan G (1998). Pharmacological and molecular characterisation of beta-adrenoceptors in adult rat diaphragm muscle. Respir Physiol 112: 1-12.
15. Criswell DS, Powers SK, Herb RA (1996). Clenbuterol-induced fiber type transition in the soleus of adult rats. Eur J Appl Physiol Occup Physiol 74: 391-396.
16. DeBellis RJ (2005). Mechanism of action of long-acting bronchodilators. Clin Pulm Med 12: S10-S12.
17. Derom E, Gayan-Ramirez G, Gurrieri G, de Bock V, Decramer M (1997). Broxaterol increases force output of fatigued canine diaphragm more than salbutamol. Am J Respir Crit Care Med 155: 181-185.
18. Disatnik MH, Sampson SR, Shainberg A (1990). Characterization of beta-adrenoceptors on rat skeletal muscle cells grown in vitro. Biochem Pharmacol 40: 1043-1048.
19. Dodd SL, Koesterer TJ (2002). Clenbuterol attenuates muscle atrophy and dysfunction in hindlimb-suspended rats. Aviat Space Environ Med 73: 635-639.
20. Dunleavy M, Bradford A, O'Halloran KD (2008). Oxidative stress impairs upper airway muscle endurance in an animal model of sleep-disordered breathing. Adv Exp Med Biol 605: 458-462.
21. Fredsted A, Gissel H, Ortenblad N, Clausen T (2012). Effects of β-agonists on force during and following anoxia in rat extensor digitorum longus muscle. J Appl Physiol 112: 2057-2067.
22. Ha TN, Posterino GS, Fryer MW (1999). Effects of terbutaline on force and intracellular calcium in slow-twitch skeletal muscle fibres of the rat. Br J Pharmacol 126: 1717-1724.
23. Hayes A, Williams DA (1994). Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice. Clinical Exp Pharmacol Physiol 21: 757-765.
24. Hayes A, Williams DA (1997). Contractile properties of clenbuterol-treated mdx muscle are enhanced by low intensity swimming. J App Physiol 82: 435-439.
25. Hesketh JE, Campbell GP, Lobley GE, Maltin CA, Acamovic F, Palmer RM (1992). Stimulation of actin and myosin synthesis in rat gastrocnemius muscle by clenbuterol; evidence for translational control. Comp Biochem Physiol C 102: 23-27.
26. Hoeks J, van Baak MA, Hesselink MKC et al (2003). Effect of beta1- and beta2-adrenergic stimulation on energy expenditure, substrate oxidation, and UCP3 expression in humans. Am J Physiol Endocrinol Metab 285: E775-E782.
27. Howell S, Roussos C (1984). Isoproterenol and aminophylline improve contractility of fatigued canine diaphragm. Am Rev Respir Dis 129: 118-124.
28. Howell S, Fitzgerald RS, Roussos C (1986). Effects of aminophylline and salbutamol on diaphragmatic force during compensated metabolic acidosis. Am Rev Respir Dis 133: 407-413.
29. Hudgel DW, Thanakitcharu S (1998). Pharmacologic treatment of sleep-disordered breathing. Am J Respir Crit Care Med 158: 691-699.
30. Ito T, Fujimura N, Omote K, Namiki A (2006). A selective beta2-adrenergic agonist, terbutaline, improves sepsis-induced diaphragmatic dysfunction in the rat. Life Sci 79: 905-912.
31. Jones SW, Baker DJ, Gardiner SM, Bennett T, Timmons JA, Greenhaff PL (2004). The effect of the beta2-adrenoceptor agonist prodrug BRL-47672 on cardiovascular function, skeletal muscle myosin heavy chain, and MyoD expression in the rat. J Pharmacol Exp Ther 311: 1225-1231.
32. Julien JY, Martin JG, Ernst P et al (2009). Prevalence of obstructive sleep apnea-hypopnea in severe versus moderate asthma. J Allergy Clin Immunol 124: 371-376.
33. Kim YS, Sainz RD, Molenaar P, Summers RJ (1991). Characterization of beta 1- and beta 2-adrenoceptors in rat skeletal muscles. Biochem Pharmacol 42: 1783-1789.
34. Lavie P, Halperin E, Zomer J, Alroy G (1981). Across-night lengthening of sleep apneic episodes. Sleep 4: 279-282.
35. MacLennan PA, Edwards RH (1989). Effects of clenbuterol and propranolol on muscle mass. Evidence that clenbuterol stimulates muscle beta-adrenoceptors to induce hypertrophy. Biochem J 264: 573-579.
36. McCormick C, Alexandre L, Thompson J, Mutungi G (2010). Clenbuterol and formoterol decrease force production in isolated intact mouse skeletal muscle fiber bundles through a beta2-adrenoceptor-independent mechanism. J Appl Physiol 109: 1716-1727.
37. McGuire M, MacDermott M, Bradford A (2002). The effects of chronic episodic hypercapnic hypoxia on rat upper airway muscle contractile properties and fiber-type distribution. Chest 122: 1400-1406.
38. McMorrow C, Fredsted A, Carberry J et al (2011). Chronic hypoxia increases rat diaphragm muscle endurance and sodium-potassium ATPase pump content. Eur Respir J 37: 1474-1481.
39. Navegantes LC, Resano NM, Migliorini RH, Kettelhut IC (2001). Catecholamines inhibit Ca(2+)-dependent proteolysis in rat skeletal muscle through beta(2)-adrenoceptors and cAMP. Am J Physiol Endocrinol Metab 281: E449-E454.
40. Navegantes LCC, Resano NMZ, Baviera AM, Migliorini RH, Kettelhut IC (2004). Effect of sympathetic denervation on the rate of protein synthesis in rat skeletal muscle. Am J Physiol Endocrinol Metab 286: E642-E647.
41. Nevzorova J, Bengtsson T, Evans BA, Summers RJ (2002). Characterization of the beta-adrenoceptor subtype involved in mediation of glucose transport in L6 cells. Br J Pharmacol 137: 9-18.
42. Numata H, Suzuki S, Miyashita A, Suzuki M, Okubo T (1993). Effects of beta 2-agonists on the contractility of fatigued canine diaphragm in vivo. Respir Physiol 94: 25-34.
43. O'Connell RA, Carberry J, O'Halloran KD (2013). Sternohyoid and diaphragm muscle form and function during postnatal development in the rat. Exp Physiol 98: 1386-1400.
44. O'Halloran KD (2006). Effects of nicotine on rat sternohyoid muscle contractile properties. Respir Physiol Neurobiol 150: 200-210.
45. O'Halloran KD, Curran AK, Bradford A (1996). Effect of almitrine on ventilation and on diaphragm and geniohyoid muscle activity in the rat. Clin Sci 91: 337-345.
46. Oksenberg A, Khamaysi I, Silverberg DS (2001). Apnoea characteristics across the night in severe obstructive sleep apnoea: influence of body posture. Eur Respir J 18: 340-346.
47. Petrof BJ, Pack AI, Kelly AM, Eby J, Hendricks JC (1994). Pharyngeal myopathy of loaded upper airway in dogs with sleep apnea. J Appl Physiol 76: 1746-1752.
48. Petrof BJ, Hendricks JC, Pack AL (1996). Does upper airway injury trigger a vicious cycle in obstructive sleep apnea? Hypothesis Sleep 19: 465-471.
49. Prasad B, Nyenhuis SM, Weaver TE (2014). Obstructive sleep apnea and asthma: associations and treatment implications. Sleep Med Rev 18: 165-171.
50. Reeds PJ, Hay SM, Dorwood PM, Palmer RM (1986). Stimulation of muscle growth by clenbuterol: lack of effect on muscle protein biosynthesis. Br J Nutr 56: 249-258.
51. Reid MB, Miller MJ (1989). Theophylline does not increase maximal tetanic force or diaphragm endurance in vitro. J Appl Physiol 67: 1655-1661.
52. Ryall JG, Sillence MN, Lynch GS (2006). Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses. Br J Pharmacol 147: 587-595.
53. Salles C, Terse-Ramos R, Souza-Machado A, Cruz ÁA (2013). Obstructive sleep apnea and asthma. J Bras Pneumol 39: 604-612.
54. Sears M, Lotvall J (2005). Past, present and future-β-agonists in asthma management. Respir Med 99: 152-170.
55. Sears MR, Ottosson A, Radner F, Suissa S (2009). Long-acting β-agonists: a review of formoterol safety data from asthma clinical trials. Eur Respir J 33: 21-32.
56. Shortt CM, Fredsted A, Bradford A, O'Halloran KD (2013). Diaphragm muscle remodeling in a rat model of chronic intermittent hypoxia. J Histochem Cytochem 61: 487-499.
57. Shortt CM, Fredsted A, Chow HB et al (2014). Reactive oxygen species mediated diaphragm fatigue in a rat model of chronic intermittent hypoxia. Exp Physiol 99: 688-700.
58. Skelly JR, Bradford A, Jones JFX, O'Halloran KD (2010). Superoxide scavengers improve rat pharyngeal dilator muscle performance. Am J Respir Cell Mol Biol 42: 725-731.
59. Skelly JR, Edge D, Shortt CM, Jones JFX, Bradford A, O'Halloran KD (2012). Tempol ameliorates pharyngeal dilator muscle dysfunction in a rodent model of chronic intermittent hypoxia. Am J Respir Cell Mol Biol 46: 139-148.
60. Skelly JR, Rowan SC, Jones JFX, O'Halloran KD (2013). Upper airway dilator muscle weakness following intermittent and sustained hypoxia in the rat: effects of a superoxide scavenger. Physiol Res 62: 187-196.
61. Supinski GS, DiMarco AF, Gonzalez J, Altose MD (1990). Effect of norepinephrine on diaphragm contractility and blood flow. J Appl Physiol 69: 2019-2028.
62. Sutherland K, Lee RWW, Cistulli PA (2012). Obesity and craniofacial structure as risk factors for obstructive sleep apnoea: impact of ethnicity. Respirology 17: 213-222.
63. Suzuki S, Numata H, Sano F, Yoshiike Y, Miyashita A, Okubo T (1988). Effects and mechanism of fenoterol on fatigued canine diaphragm. Am Rev Respir Dis 137: 1048-1054.
64. Uzuki M, Yamakage M, Fujimura N, Namiki A (2006). Preferable inotropic action of procaterol, a potent bronchodilator, on impaired diaphragmatic contractility in an intraabdominal septic model. J Anesth 20: 145-148.
65. Uzuki M, Yamakage M, Fujimura N, Namiki A (2007). Direct inotropic effect of the beta-2 receptor agonist terbutaline on impaired diaphragmatic contractility in septic rats. Heart Lung 36: 140-147.
66. Van de Graaff WB, Gottfried SB, Mitra J, van Lunteren E, Cherniack NS, Strohl KP (1984). Respiratory function of hyoid muscles and hyoid arch. J Appl Physiol Respir Environ Exerc Physiol 57: 197-204.
67. Van der Heijden HF, Zhan WZ, Prakash YS, Dekhuijzen PN, Sieck GC (1998). Salbutamol enhances isotonic contractile properties of rat diaphragm muscle. J Appl Physiol 85: 525-529.
68. Van der Heijen HF, Heunks LM, Folgering H, van Herwaarden CL, Dekhuijzen PN (1999). beta2-adrenoceptor agonists reduce the decline of rat diaphragm twitch force during severe hypoxia. Am J Physiol 276: L474-L480.
69. Van Lunteren E, Haxhiu MA, Cherniack NS (1987). Relation between upper airway volume and hyoid muscle length. J Appl Physiol 63: 1443-1449.
70. Van Lunteren E, Moyer M, Torres A (1995). Effect of K+ channel blockade on fatigue in rat diaphragm muscle. J Appl Physiol 79: 738-747.
71. Van Lunteren E, Vafaie H, Miller MJ (1996). Effects of theophylline on pharyngeal dilator and diaphragm muscle contractile properties. Respiration 63: 88-93.
72. Veasey SC (2001). Pharmacotherapies for obstructive sleep apnea: how close are we? Curr Opin Pulm Med 7: 399-403.
73. Veasey SC (2003). Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential. Am J Respir Med 2: 21-29.
74. Viires N, Aubier M, Murciano D, Marty C, Pariente R (1986). Effects of theophylline on isolated diaphragmatic fibers. A model for pharmacologic studies on diaphragmatic contractility. Am Rev Respir Dis 133: 1060-1064.
75. Wheatley JR, Mezzanotte WS, Tangel DJ, White DP (1993a). Influence of sleep on genioglossus muscle activation by negative pressure in normal men. Am Rev Respir Dis 148: 597-605.
76. Wheatley JR, Tangel DJ, Mezzanotte WS, White DP (1993b). Influence of sleep on response to negative airway pressure of tensor palatini muscle and retropalatal airway. J Appl Physiol 75: 2117-2124.
77. Williams R, Caron M, Daniel K (1984). Skeletal muscle beta-adrenergic receptors: variations due to fiber type and training. Am J Physiol 246: E160-E167.
78. Yimlamai T, Dodd SL, Borst SE, Park S (2005). Clenbuterol induces muscle-specific attenuation of atrophy through effects on the ubiquitin-proteasome pathway. J Appl Physiol 99: 71-80.
79. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993). The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328: 1230-1235.
80. Zeman RJ, Ludemann R, Easton TG, Etlinger JD (1988). Slow to fast alterations in skeletal muscle fibers caused by clenbuterol, a beta 2-receptor agonist. Am J Physiol 254: E726-E732.